White blood cell treatment could prevent leading cause of fetal death

December 12, 2016, Queen Mary, University of London
pregnancy

Treating a type of white blood cell using hormones could improve the development of the placenta in women with pregnancy complications, according to early research led by Queen Mary University of London (QMUL) involving mice and human blood samples.

Pre-eclampsia is a condition in some that results in poor maternal vessel development in the placenta, leading to poor foetal growth. According to the World Health Organization, it is one of the leading causes of maternal and foetal morbidity and mortality in both the developed and developing world, occurring in 2-8 per cent of all pregnancies.

The study, funded by the Wellcome Trust and British Heart Foundation and published in Proceedings of the National Academy of Sciences, looked specifically at neutrophils - short-lived that act as the first line of defence in infections - and discovered a new role for them in maintaining a healthy pregnancy.

The researchers studied and compared the blood from healthy and pre-eclamptic pregnant women. In the healthy women's blood, they saw that neutrophils interacted with T-cells - another type of white blood cell essential for the immune system. In contrast with the healthy pregnancies, the neutrophils failed to interact with the T-cells in the blood from pre-eclamptic women.

The authors suggest that there are signs that, in healthy pregnancies, neutrophils play a role in helping the T-cells to promote blood vessel growth and give rise to normal placental development, suggesting that this could be a potential therapeutic target for .

In tests outside of the human body, the team treated the neutrophils from pre-eclamptic women with pregnancy hormones progesterone and estriol, and found that they were able to begin normal interactions with their T-cells.

Further tests in pregnant mice with pre-eclampsia found that if neutrophils underwent the same hormone treatment, and were re-infused into the mouse, placental development began to return to normal.

Study author Dr Suchita Nadkarni from QMUL said: "Although we're a long way off and need to confirm these results in a much larger cohort of patients, this could eventually form part of therapy for pregnancy complications. If we could replicate in humans what we've done in mice, and re-introduce the treated neutrophils back into their blood, we may see normal placental development in pregnant women diagnosed with pre-eclampsia.

"In the meantime, however, these results give us a much better insight into how the maternal immune system works during pregnancy, and why in some cases it might not work and lead to complications."

Explore further: Maternal blood test may predict birth complications

More information: Neutrophils induce proangiogenic T cells with a regulatory phenotype in pregnancy, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1611944114

Related Stories

Maternal blood test may predict birth complications

October 24, 2016
A protein found in the blood of pregnant women could be used to develop tests to determine the health of their babies and aid decisions on early elective deliveries, according to an early study led by Queen Mary University ...

Kidney disease risk for some pregnant women

November 17, 2016
Research from the University of Aberdeen has found that that there was an increased risk of chronic kidney disease later in life for mothers who had high blood pressure during pregnancy.

Study links small RNA molecule to pregnancy complication

October 24, 2016
A family of small RNA molecules affects the development of cells that give rise to the placenta - an organ that transfers oxygen and nutrients from mother to fetus—in ways that could contribute to a serious pregnancy complication, ...

Pre-pregnancy heart abnormalities may predict recurrent preeclampsia risk

February 22, 2016
Women who had pregnancy-related high blood pressure multiple times had recognizable heart abnormalities between pregnancies that could help predict their risk for heart and blood vessel disease during subsequent pregnancies ...

Genetics point to serious pregnancy complication

November 15, 2012
New research at the University of Adelaide has revealed a genetic link in pregnant mums - and their male partners - to pre-eclampsia, a life-threatening complication during pregnancy.

Researcher investigating whether self-monitoring of blood pressure can result in earlier pre-eclampsia diagnosis

July 12, 2016
An academic from City University London is working with colleagues from across the UK to explore whether giving pregnant women the means to monitor their own blood pressure and urine safely from home can result in an earlier ...

Recommended for you

Study reviews what causes chronic itching and scratching

November 21, 2018
Relentless itch is a feature of many skin disorders, such as eczema and psoriasis, but the cause of this itch—and what drives us to scratch—is somewhat mysterious. A review appearing November 21 in the journal Trends ...

Regulating the immune system's 'regulator'

November 20, 2018
A research team at the Academy of Immunology and Microbiology, within the Institute for Basic Science (IBS) has discovered a possible therapeutic target that pulls the reins of immunity. In Nature Communications, the scientists ...

New immunotherapy improves MS symptoms

November 20, 2018
A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has improved symptoms and quality of life for the majority of patients.

Scientists unveil completely human platform for testing age-specific vaccine responses

November 20, 2018
A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines—outside the body. The practical, cost-effective new platform, using ...

To resolve inflammation, location matters

November 19, 2018
Health conditions that involve inflammation run the gamut, from multiple sclerosis and lupus to arthritis, diabetes, and cancer. While inflammation can serve as a normal response to help the body deal with injury or infection, ...

New insights into how an ordinary stem cell becomes a powerful immune agent

November 19, 2018
How do individual developing cells choose and commit to their "identity"—to become, for example, an immune cell, or a muscle cell, or a neuron?

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.